No patents, no problems. We make the world so much more difficult by granting patent monopolies for drugs. Not only do they make drugs expensive, they encourage companies to lie about their safety and effectiveness.
"...coupled with mandatory switching. Contrast this to the United States, where recent analyses show that in 2018, biosimilars only achieved 9% ($91 million) of the $1 billion in cost savings the CBO projected."
The rest of the article talks about the aggressive use of patents, market manipulation..

Comments